Richard D. Francis
CIK: 0001673277
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct13K shares- - Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct6.2K shares at avg. $34.35$211K - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct20K shares at avg. $31.67$634K - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct42.5K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct23.4K shares at avg. $32.46$759K - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct50.2K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
136.7K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct891.3K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct67.2K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct30.9K shares at avg. $32.36$1.0M - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct412K shares at avg. $32.36$13.3M - Feb 15, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct286.1K shares at avg. $34.22$9.8M - Feb 15, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct161.7K shares- - Feb 15, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct161.7K shares at avg. $34.22$5.5M - Feb 15, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct620.1K shares- - Jan 27, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
891.3K shares- - Jan 27, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
620.1K shares- - Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
52.2K shares- - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
169.8K shares- - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct8.3K shares at avg. $15.91$131K - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct15.5K shares at avg. $15.73$244K - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct50.2K shares- - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct6.5K shares at avg. $15.56$100K - Mar 3, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct24.9K shares at avg. $16.19$403K - Mar 3, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct67.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 13,043 | - | $0 | Direct |
| Jun 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 6,153 | $34.35 | $211,356 | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 20,025 | $31.67 | $634,160 | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 42,452 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 23,393 | $32.46 | $759,442 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 50,223 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 136,736 | - | - | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 891,315 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 67,231 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 30,903 | $32.36 | $1,000,018 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 412,032 | $32.36 | $13,333,314 | Direct |
| Feb 15, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 286,122 | $34.22 | $9,792,268 | Direct |
| Feb 15, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 161,656 | - | $0 | Direct |
| Feb 15, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 161,656 | $34.22 | $5,532,531 | Direct |
| Feb 15, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 620,110 | - | $0 | Direct |
| Jan 27, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 891,315 | - | - | Direct |
| Jan 27, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 620,110 | - | - | Direct |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 52,173 | - | - | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 169,811 | - | - | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 8,259 | $15.91 | $131,427 | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 15,514 | $15.73 | $244,107 | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 50,223 | - | - | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 6,450 | $15.56 | $100,347 | Direct |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 24,892 | $16.19 | $402,889 | Direct |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 67,231 | - | - | Direct |
1-25 of 28 transactions
About Francis Richard D
Francis Richard D (SEC CIK 0001673277) files insider reports with the SEC as President and CEO of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) and Director of METTLER TOLEDO INTERNATIONAL INC/ (MTD).
Signal8 holds 12 ownership filings by Francis Richard D, all Form 4s, filed between Nov 14, 2024 and Jun 8, 2026. Those filings report 28 transactions, from Nov 12, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Francis Richard D's filings is in TEL AVIV.
Recent filings by Francis Richard D
- Jun 5, 2026: Option exercise of TEVA shares (Form 4, code M).
- Jun 5, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Mar 5, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Mar 5, 2026: Option exercise of TEVA shares (Form 4, code M).
- Mar 4, 2026: Open-market sale of TEVA shares (Form 4, code S).
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development